Emerging Technologies in Cell Therapy
Thursday, May 30, 2024 09:15 AM - 10:15 AM
Room 212-214
Concurrent Session
Chair
Artificial intelligence, machine learning, and agent-based modeling are proving to be powerful tools not just for cell product manufacturing but for understanding and predicting biologic and potential therapeutic actions of cell-based products. Leading experts in these areas will provide a broad and provocative overview including the generation of living cell-based robots.
- Alice Bertaina, MD, PhD, Stanford School of Medicine
- R. Chase Cockrell, PhD, University of Vermont, United States, "Using AI to Enable the Development of Medical Digital Twins"
- Will Johnson, PhD, Asimov Inc, United States, "From genetic design to process performance: toward holistic optimization of upstream viral vector bioprocesses"
- Andras Nagy, PhD, Lunenfeld-Tanenbaum Research Institute, Canada, "Cell Therapy v2.0: Safe and Immune-Cloaked Allogeneic Therapeutic Cells"
Artificial intelligence, machine learning, and agent-based modeling are proving to be powerful tools not just for cell product manufacturing but for understanding and predicting biologic and potential therapeutic actions of cell-based products. Leading experts in these areas will provide a broad and provocative overview including the generation of living cell-based robots.
